Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Prediction for Antihypertensive Medications in Cirrhotic Patients Using Simcyp Program: Applications in Clinical Practice

NCT07397481 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT07397481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Prediction for Antihypertensive Medications in Cirrhotic Patients Using Simcyp Program: Applications in Clinical Practice
Lead sponsor
Kafrelsheikh University
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2024
Completion date
June 1, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension, liver cirrhosis